Pharmaceutical Formulation Development Services
Quay Pharma is widely recognised as leading experts in all aspects of pharmaceutical development and dosage form optimisation for a wide range of product types, including those that have poor solubility or bioavailability.
Details
We also have knowledge and expertise in the formulation development of modified or targeted release within the body. A comprehensive selection of supporting technologies underpins our professional expertise, and all prototype formulations undergo extensive screening and stability evaluation in a non-GMP environment.
Once Quay Pharma has investigated the fundamental properties of a drug, we can prepare a formulation development strategy to bring it rapidly and effectively to First in Human (FIH) studies and on towards clinical use.
The formulations we create are designed to match our clients’ requirements and resources precisely. Significantly, they are provided royalty-free, so there is no commitment or limiting factor on any future development.
Our work is carried out on a purely fee-for-service basis, with our aim to provide the best formulation development and the best chance of clinical success. An extensive suite of formulation development services is offered at Quay Pharma.
Development Capabilities - Oral Dosage Forms
- Immediate release and controlled release tablets
- Multilayer tablets
- Immediate release capsules
- Oral multiparticulates such as beads, pellets and mini-tablets
- Liquid and semi-solid filled capsules
- Fast dispersible tablets
- Coating of tablets, capsules and pellets
- Micro-encapsulation using spray drying
- Oral liquids and suspensions
- Non-sterile, live bacteria for oral delivery
- Liquids and semi-solids for topical delivery, such as creams, ointments, lotions and gels
- Parenteral formulations for early phase toxicity evaluation
- Buccal delivery
- Nasal sprays
- Dental products
Customer reviews
No reviews were found for Pharmaceutical Formulation Development Services. Be the first to review!